A Case Report of Dapagliflozin-Induced Nodular Vasculitis

被引：0

作者：

Kocabas, Muhammet ^{[1
]}

Yarar, Zeliha ^{[1
]}

Cordan, Ilker ^{[2
]}

Can, Mustafa ^{[1
]}

Caliskan Burgucu, Hatice ^{[1
]}

Aydemir, Harun ^{[3
]}

Karakose, Melia ^{[1
]}

Kulaksizoglu, Mustafa ^{[1
]}

Karakurt, Feridun ^{[1
]}

机构：

[1] Necmettin Erbakan Univ, Meram Fac Med, Dept Endocrinol & Metab, Konya, Turkey

[2] Edirne Sultan 1 Murat State Hosp, Clin Endocrinol & Metab, Edirne, Turkey

[3] Necmettin Erbakan Univ, Meram Fac Med, Dept Rheumatol, Konya, Turkey

来源：

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2021年 / 25卷 / 01期

关键词：

Nodular vasculitis; dapagliflozin; antinuclear antibodies; sodium-glucose cotransporter-2 inhibitors; diabetes mellitus; SGLT2; INHIBITORS; DIAGNOSIS;

D O I：

10.25179/tjem.2020-80188

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nodular vasculitis (NV), first described by Montgomery in 1945 for erythema induratum-like lesions, is a rare form of panniculitis that is particularly localized on the calves. Characterized by plaques and erythematous nodules, NV may often show ulceration and draining. It is known as a reactive disease associated with many causative factors. Several NV cases due to infectious or non-infectious causative factors have been reported, but no case of NV due to sodium-glucose cotransporter-2 inhibitors (SGLT2i) has yet been reported. In this case report, we presented a case diagnosed with NV, who presented with tender, erythematous, eroded plaques with hemorrhagic-purulent discharge on both legs during treatment with dapagliflozin (an SGLT2i).

引用

页码：129 / 132

页数：4

共 50 条

[21] Possibilities of dapagliflozin-induced cardioprotection on doxorubicin plus cyclophosphamide mode of chemotherapy-induced cardiomyopathy
Avagimyan, Ashot
Sheibani, Mohammad
Pogosova, Nana
Mkrtchyan, Lusine
Yeranosyan, Hasmik
Aznauryan, Anahit
Sahaakyan, Karmen
Fogacci, Federica
Cicero, Arrigo
Shafie, Davood
Sarrafzadegan, Nizal
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 391
[22] Correction: Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
Xudong Yang
Lifeng Wang
Liangzhi Zhang
Xia Zhai
Xiusheng Sheng
Hengjun Lin
Helong Quan
Diabetology & Metabolic Syndrome, 15
[23] AspirinDrug induced cutaneous vasculitis: case report
Reactions Weekly, 2023, 1985 (1) : 87 - 87
[24] Cefuroxime induced leukocytoclastic vasculitis: a case report
Akkelle, E.
Yazicioglu, M.
Cetinkaya, E.
Ozkayin, N.
Yalcin, O.
ALLERGY, 2011, 66 : 183 - 183
[25] Case Report of Sotalol Induced IgA Vasculitis
Mohammed, Biniyam T.
Alchalabi, Marwah
Laskova, Anna
Sun, Chenyu
Lodhi, Owais
Gerais, Yasmin
Alkhidir, Ayah Galal Abdelrahman
CURRENT RHEUMATOLOGY REVIEWS, 2023, 19 (01) : 113 - 119
[26] Glimepiride-induced vasculitis: a case report
Ben Salem, Chaker
Hmouda, Houssem
Bouraoui, Kamel
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (01) : 113 - 114
[27] Ampicillin induced cutaneous vasculitis: a case report
Mogosan, C.
Vostinaru, O.
Palage, M.
Farcas, A. M.
Ciumarnean, L.
Achimas, A. C.
Bojita, M. T.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 90 - 91
[28] Furosemide induced hypersensitivity vasculitis: a case report
Affes, H.
Hammami, B.
Ghozzi, H.
Hammami, S.
Ayedi, L.
Sahnoun, Z.
Benjmaa, M.
Zeghal, Kh.
DRUG SAFETY, 2006, 29 (10) : 951 - 951
[29] Sofosbuvir induced leucocytoclasic vasculitis: a case report
Campione, Elena
Dattola, Annunziata
Di Prete, Monia
Di Paolo, Daniele
Ferlosio, Amedeo
Orlandi, Augusto
Bianchi, Luca
BMC DERMATOLOGY, 2019, 19
[30] Dapagliflozin induced hypernatremia via osmotic diuresis: a case report
Sugiyama, Juri
Ryuge, Akihiro
Mitsubayashi, Kenta
Ito, Masashi
Matsumoto, Naoki
Takeuchi, Riku
Azuma, Kiho
Hachiya, Asaka
Asano, Marina
Nakamura, Tomonobu
CEN CASE REPORTS, 2024, 13 (01) : 9 - 13

← 1 2 3 4 5 →